This article is more than 5 years old. Information may no longer be current.

Glaukos begins trading on NYSE

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Glaukos stock began trading on the New York Stock Exchange on June 25, according to a press release.

The company had previously announced its initial public offering of 6 million shares of common stock at a price of $18 per share. The first day of trading closed with the stock at $31.22 per share.

In addition, the underwriters participating in the IPO exercised their 30-day option to purchase an additional 900,000 shares from the company at $18 per share.

Total net proceeds from the offering and option exercise are expected to be approximately $112.3 million after deducting underwriting discounts and commissions and estimated offering expenses, the release said.

The offering, which is subject to customary closing conditions, is scheduled to close June 30, the release said.